Uncomplicated Urinary Tract Infection (uUTI) — Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033
Uncomplicated Urinary Tract Infection (UTI) is caused by bacteria that affect the bladder and its supporting tissues. Individuals with uncomplicated urinary tract infections do not have any immunocompromised states, diabetes, recent urologic surgery, pregnancy, or structural abnormalities of the urinary system. Lower tract UTI or cystitis are other names for an uncomplicated UTI. Women are more vulnerable to UTIs due to pathogenic bacteria that migrate from the rectum and perineum to the periurethral region. Women are more susceptible than men because they have significantly shorter urethras. These microorganisms cause an inflammatory response known as cystitis when they enter the bladder’s mucosal wall after ascending the urethra. Sexual activity encourages the entrance and inoculation of bacteria into the bladder, which is one of the leading causes of UTIs. The majority of the time, asymptomatic bacteriuria is benign and doesn’t need to be treated — except for immunocompromised individuals, transplant recipients, and pregnant women. Urine cultures are generally not necessary for simple UTIs. However, some doctors still advise them because of the rising trends in antibiotic resistance and to assist in distinguishing recurrent infections from relapsing ones. All male patients with diabetes mellitus, those on immunosuppressive therapies, and expectant mothers should have their urine cultured. According to traditional teaching for diagnosing a UTI, the criteria for culture-contaminated urine are greater than 100,000 colony-forming units per millilitre (CFU/mL). Differential diagnoses for an uncomplicated UTI are Food issues, Herpes simplex, Pelvic inflammatory disease, Prostatitis, and Overactive bladder. The prevalence in women over 65 is approximately 20%, compared with approximately 11% in the overall population. Nitrofurantoin is arguably the preferred choice for uncomplicated UTIs, although it is bacteriostatic, not bacteriocidal, and must be administered for 5 to 7 days. It is the recommended low-dose, long-term prevention medication in patients with recurrent UTIs.
- In the US, between 50% and 60% of adult women will have at least one UTI in their life, and close to 10% of postmenopausal women indicate that they had a UTI.
Thelansis’s “Uncomplicated Urinary Tract Infection (uUTI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Uncomplicated Urinary Tract Infection (uUTI) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Uncomplicated Urinary Tract Infection (uUTI) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Uncomplicated Urinary Tract Infection (uUTI) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
